HERENTALS, Belgium--(BUSINESS WIRE)--Kemin Pharma, a division of Kemin Industries South Asia Private Limited, is pleased to announce the opening of its new offices in Chennai, India. The new facility enables Kemin Pharma to expand its R&D activities in India, as the organization advances its pipeline of human therapeutic products through clinical development and the launch of its lead product, the Bacillus subtilis probiotic PB6 into global markets.
